Screening key target genes for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on bioinformatics and gene network
Journal Title: Precision Medicine Research - Year 2020, Vol 2, Issue 2
Abstract
Background: To provide a reference for the clinical development of drugs to suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods: Retrieving genes related to SARS-CoV-2 with Genecards database and then importing the obtained gene data into the database of Database for Annotation, Visualization and Integrated Discovery (DAVID) (Version 6.8) to collect relevant information on pathways and genes. Genes enriched in the first 20 most significant pathways and genes with gene occurrence frequency ≥ 6 were respectively imported into the STRING database to construct protein-protein interaction (PPI) network diagrams, and the two network diagrams were compared. Results: In the two network graphs, RELA, MAPK1, MAPK3, PIK3CA, PIK3R1, MAPK8, JAK1, STAT1, TNF, IL6, MAPK14, and IL1B ranked higher, and the occurrence frequency of the first 20 pathways was ≥ 10. Conclusion: The pathogenesis of SARS-CoV-2 is associated with multiple pathways such as influenza A, TNF signaling pathway, chemokine signaling pathway, toll-like receptor signaling pathway, T cell receptor signaling pathway et al. RELA, MAPK1, MAPK3, PIK3CA, PIK3R1, MAPK8, JAK1, STAT1, TNF, IL6, MAPK14 and IL1B are closely related to SARS-CoV-2 and need further study. Gene interaction network and pathway analysis of diseaseassociated genes will help us to screen the key target genes of SARS-CoV-2 and provide a reference for the clinical development of effective drugs.
Authors and Affiliations
Zhi-Hua Yang， Hai-Feng Yan, Lin-Wang, Miao-Ru Han
Keywords
Related Articles
- EP ID EP685210
- DOI 10.12032/PMR201900027
- Views 193
- Downloads 0
Screening key target genes for pulmonary arterial hypertension based on bioinformatics
Objective: Screening key target genes for pulmonary arterial hypertension (PAH) based on bioinformatics to provide a reference for the clinical development of drugs to cure PAH. Methods: The keyword “pulmonary arterial h...
A network pharmacology approach to investigate the mechanism of “Huangqi-Shanzhuyu” in the treatment of diabetic nephropathy
Background: To explore the action mechanism of Huangqi (Radix Astragali) and Shanzhuyu (Fructus Corni) in the treatment of diabetic nephropathy based on network pharmacology, aiming to provide a basis for clinical appli...
Screening key target genes for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on bioinformatics and gene network
Background: To provide a reference for the clinical development of drugs to suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods: Retrieving genes related to SARS-CoV-2 with Genecards database...
Use of network pharmacology and molecular docking to explore the potential mechanism governing the efficacy of Jinhuaqinggan granules in the treatment of novel coronavirus-induced pneumonia
Background: Now that the epidemic of new coronavirus pneumonia (corona virus disease 2019) is spreading all over the world, Jinhuaqinggan granules in the Chinese treatment plan has been proved to be an effective Chinese...
Network pharmacological approach to explore the mechanisms of Lianhua Qingwen capsule in coronavirus disease 2019
Background: This study aimed to explore the molecular mechanisms of the active compounds of Lianhua Qingwen capsule in the treatment of coronavirus disease 2019 by using systemic pharmacology approach. Methods: In this...